{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:21:55Z","timestamp":1793413315615,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T00:00:00Z","timestamp":1602547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T00:00:00Z","timestamp":1602547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000912","name":"March of Dimes Foundation","doi-asserted-by":"publisher","award":["20-FY02-56"],"award-info":[{"award-number":["20-FY02-56"]}],"id":[{"id":"10.13039\/100000912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000102","name":"Health Resources and Services Administration","doi-asserted-by":"publisher","award":["R40MC27443"],"award-info":[{"award-number":["R40MC27443"]}],"id":[{"id":"10.13039\/100000102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000102","name":"Health Resources and Services Administration","doi-asserted-by":"publisher","award":["UJ2MC31074"],"award-info":[{"award-number":["UJ2MC31074"]}],"id":[{"id":"10.13039\/100000102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21ES011666"],"award-info":[{"award-number":["R21ES011666"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HD041702"],"award-info":[{"award-number":["R01HD041702"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21HD066471"],"award-info":[{"award-number":["R21HD066471"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01AI090727"],"award-info":[{"award-number":["U01AI090727"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21AI079872"],"award-info":[{"award-number":["R21AI079872"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HD086013"],"award-info":[{"award-number":["R01HD086013"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HD098232"],"award-info":[{"award-number":["R01HD098232"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R03HD096136"],"award-info":[{"award-number":["R03HD096136"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21AI154233"],"award-info":[{"award-number":["R21AI154233"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["R01ES031272"],"award-info":[{"award-number":["R01ES031272"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Preeclampsia and preterm delivery (PTD) are believed to affect women\u2019s long-term health including cardiovascular disease (CVD), but the biological underpinnings are largely unknown. We aimed to test whether maternal postpartum metabolomic profiles, especially CVD-related metabolites, varied according to PTD subtypes with and without preeclampsia, in a US urban, low-income multi-ethnic population.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This study, from the Boston Birth Cohort, included 980 women with term delivery, 79 with medically indicated PTD (mPTD) and preeclampsia, 52 with mPTD only, and 219 with spontaneous PTD (sPTD). Metabolomic profiling in postpartum plasma was conducted by liquid chromatography-mass spectrometry. Linear regression models were used to assess the associations of each metabolite with mPTD with preeclampsia, mPTD only, and sPTD, respectively, adjusting for pertinent covariates. Weighted gene coexpression network analysis was applied to investigate interconnected metabolites associated with the PTD\/preeclampsia subgroups. Bonferroni correction was applied to account for multiple testing.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 380 known metabolites were analyzed. Compared to term controls, women with mPTD and preeclampsia showed a significant increase in 36 metabolites, mainly representing acylcarnitines and multiple classes of lipids (diacylglycerols, triacylglycerols, phosphocholines, and lysophosphocholines), as well as a decrease in 11 metabolites including nucleotides, steroids, and cholesteryl esters (CEs) (<jats:italic>P<\/jats:italic>\u2009&lt;\u20091.3\u2009\u00d7\u200910<jats:sup>\u22124<\/jats:sup>). Alterations of diacylglycerols, triacylglycerols, and CEs in women with mPTD and preeclampsia remained significant when compared to women with mPTD only. In contrast, the metabolite differences between women with mPTD only and term controls were only seen in phosphatidylethanolamine class. Women with sPTD had significantly different levels of 16 metabolites mainly in amino acid, nucleotide, and steroid classes compared to term controls, of which, anthranilic acid, bilirubin, and steroids also had shared associations in women with mPTD and preeclampsia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In this sample of US high-risk women, PTD\/preeclampsia subgroups each showed some unique and shared associations with maternal postpartum plasma metabolites, including those known to be predictors of future CVD. These findings, if validated, may provide new insight into metabolomic alterations underlying clinically observed PTD\/preeclampsia subgroups and implications for women\u2019s future cardiometabolic health.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12916-020-01741-4","type":"journal-article","created":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T01:02:28Z","timestamp":1602550948000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Postpartum plasma metabolomic profile among women with preeclampsia and preterm delivery: implications for long-term health"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3992-1918","authenticated-orcid":false,"given":"Xiumei","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuelong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongkai","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clary B.","family":"Clish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Burd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Zuckerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank B.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,13]]},"reference":[{"key":"1741_CR1","doi-asserted-by":"crossref","unstructured":"Auger N, Potter BJ, He S, Healy-Profitos J, Schnitzer ME, Paradis G. Maternal cardiovascular disease 3 decades after preterm birth: longitudinal cohort study of pregnancy vascular disorders. Hypertension. 2020;75(3):788\u2013795.","DOI":"10.1161\/HYPERTENSIONAHA.119.14221"},{"issue":"25","key":"1741_CR2","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1161\/CIRCULATIONAHA.111.034884","volume":"124","author":"AK Bonamy","year":"2011","unstructured":"Bonamy AK, Parikh NI, Cnattingius S, Ludvigsson JF, Ingelsson E. Birth characteristics and subsequent risks of maternal cardiovascular disease: effects of gestational age and fetal growth. Circulation. 2011;124(25):2839\u201346.","journal-title":"Circulation"},{"issue":"6","key":"1741_CR3","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1161\/CIRCULATIONAHA.116.025954","volume":"135","author":"LJ Tanz","year":"2017","unstructured":"Tanz LJ, Stuart JJ, Williams PL, Rimm EB, Missmer SA, Rexrode KM, Mukamal KJ, Rich-Edwards JW. Preterm delivery and maternal cardiovascular disease in young and middle-aged adult women. Circulation. 2017;135(6):578\u201389.","journal-title":"Circulation"},{"key":"1741_CR4","doi-asserted-by":"crossref","unstructured":"Wu P, Gulati M, Kwok CS, Wong CW, Narain A, O'Brien S, Chew-Graham CA, Verma G, Kadam UT, Mamas MA. Preterm delivery and future risk of maternal cardiovascular disease: a systematic review and meta-analysis. J Am Heart Assoc. 2018;7(2):e007809.","DOI":"10.1161\/JAHA.117.007809"},{"issue":"6","key":"1741_CR5","first-page":"1","volume":"66","author":"SL Murphy","year":"2017","unstructured":"Murphy SL, Xu J, Kochanek KD, Curtin SC, Arias E. Deaths: final data for 2015. Natl Vital Stat Rep. 2017;66(6):1\u201375.","journal-title":"Natl Vital Stat Rep"},{"issue":"8","key":"1741_CR6","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1161\/CIRCULATIONAHA.117.031403","volume":"137","author":"MB Minissian","year":"2018","unstructured":"Minissian MB, Kilpatrick S, Eastwood JA, Robbins WA, Accortt EE, Wei J, Shufelt CL, Doering LV, Merz CNB. Association of spontaneous preterm delivery and future maternal cardiovascular disease. Circulation. 2018;137(8):865\u201371.","journal-title":"Circulation"},{"issue":"8","key":"1741_CR7","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.annepidem.2010.05.007","volume":"20","author":"JM Catov","year":"2010","unstructured":"Catov JM, Wu CS, Olsen J, Sutton-Tyrrell K, Li J, Nohr EA. Early or recurrent preterm birth and maternal cardiovascular disease risk. Ann Epidemiol. 2010;20(8):604\u20139.","journal-title":"Ann Epidemiol"},{"issue":"6","key":"1741_CR8","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.3945\/ajcn.113.074070","volume":"99","author":"Y Zheng","year":"2014","unstructured":"Zheng Y, Yu B, Alexander D, Steffen LM, Nettleton JA, Boerwinkle E. Metabolomic patterns and alcohol consumption in African Americans in the Atherosclerosis Risk in Communities Study. Am J Clin Nutr. 2014;99(6):1470\u20138.","journal-title":"Am J Clin Nutr"},{"issue":"26","key":"1741_CR9","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1093\/eurheartj\/ehs424","volume":"34","author":"M Magnusson","year":"2013","unstructured":"Magnusson M, Lewis GD, Ericson U, Orho-Melander M, Hedblad B, Engstrom G, Ostling G, Clish C, Wang TJ, Gerszten RE, et al. A diabetes-predictive amino acid score and future cardiovascular disease. Eur Heart J. 2013;34(26):1982\u20139.","journal-title":"Eur Heart J"},{"issue":"18","key":"1741_CR10","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1161\/CIRCULATIONAHA.111.067827","volume":"125","author":"S Cheng","year":"2012","unstructured":"Cheng S, Rhee EP, Larson MG, Lewis GD, McCabe EL, Shen D, Palma MJ, Roberts LD, Dejam A, Souza AL, et al. Metabolite profiling identifies pathways associated with metabolic risk in humans. Circulation. 2012;125(18):2222\u201331.","journal-title":"Circulation"},{"issue":"5","key":"1741_CR11","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.ahj.2012.02.005","volume":"163","author":"SH Shah","year":"2012","unstructured":"Shah SH, Sun JL, Stevens RD, Bain JR, Muehlbauer MJ, Pieper KS, Haynes C, Hauser ER, Kraus WE, Granger CB, et al. Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery disease. Am Heart J. 2012;163(5):844\u201350 e841.","journal-title":"Am Heart J"},{"issue":"6","key":"1741_CR12","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000542","volume":"2","author":"S Kalim","year":"2013","unstructured":"Kalim S, Clish CB, Wenger J, Elmariah S, Yeh RW, Deferio JJ, Pierce K, Deik A, Gerszten RE, Thadhani R, et al. A plasma long-chain acylcarnitine predicts cardiovascular mortality in incident dialysis patients. J Am Heart Assoc. 2013;2(6):e000542.","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"1741_CR13","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.atherosclerosis.2013.10.029","volume":"232","author":"S Rizza","year":"2014","unstructured":"Rizza S, Copetti M, Rossi C, Cianfarani MA, Zucchelli M, Luzi A, Pecchioli C, Porzio O, Di Cola G, Urbani A, et al. Metabolomics signature improves the prediction of cardiovascular events in elderly subjects. Atherosclerosis. 2014;232(2):260\u20134.","journal-title":"Atherosclerosis"},{"issue":"18","key":"1741_CR14","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1161\/CIRCULATIONAHA.113.002500","volume":"129","author":"C Stegemann","year":"2014","unstructured":"Stegemann C, Pechlaner R, Willeit P, Langley SR, Mangino M, Mayr U, Menni C, Moayyeri A, Santer P, Rungger G, et al. Lipidomics profiling and risk of cardiovascular disease in the prospective population-based Bruneck study. Circulation. 2014;129(18):1821\u201331.","journal-title":"Circulation"},{"issue":"21","key":"1741_CR15","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1161\/CIRCULATIONAHA.116.023233","volume":"134","author":"ZH Alshehry","year":"2016","unstructured":"Alshehry ZH, Mundra PA, Barlow CK, Mellett NA, Wong G, McConville MJ, Simes J, Tonkin AM, Sullivan DR, Barnes EH, et al. Plasma lipidomic profiles improve on traditional risk factors for the prediction of cardiovascular events in type 2 diabetes mellitus. Circulation. 2016;134(21):1637\u201350.","journal-title":"Circulation"},{"issue":"12","key":"1741_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004801","volume":"10","author":"A Ganna","year":"2014","unstructured":"Ganna A, Salihovic S, Sundstrom J, Broeckling CD, Hedman AK, Magnusson PK, Pedersen NL, Larsson A, Siegbahn A, Zilmer M, et al. Large-scale metabolomic profiling identifies novel biomarkers for incident coronary heart disease. PLoS Genet. 2014;10(12):e1004801.","journal-title":"PLoS Genet"},{"issue":"12","key":"1741_CR17","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1001\/jamacardio.2019.4130","volume":"4","author":"E Cavus","year":"2019","unstructured":"Cavus E, Karakas M, Ojeda FM, Kontto J, Veronesi G, Ferrario MM, Linneberg A, Jorgensen T, Meisinger C, Thorand B, et al. Association of circulating metabolites with risk of coronary heart disease in a European population: results from the Biomarkers for Cardiovascular Risk Assessment in Europe (BiomarCaRE) consortium. JAMA Cardiol. 2019;4(12):1270\u20139.","journal-title":"JAMA Cardiol"},{"key":"1741_CR18","doi-asserted-by":"crossref","unstructured":"Wang G, Divall S, Radovick S, Paige D, Ning Y, Chen Z, Ji Y, Hong X, Walker SO, Caruso D, et al. Preterm birth and random plasma insulin levels at birth and in early childhood. JAMA. 2014;311(6):587\u201396.","DOI":"10.1001\/jama.2014.1"},{"key":"1741_CR19","doi-asserted-by":"crossref","unstructured":"Wang X, Zuckerman B, Pearson C, Kaufman G, Chen C, Wang G, Niu T, Wise PH, Bauchner H, Xu X. Maternal cigarette smoking, metabolic gene polymorphism, and infant birth weight. JAMA. 2002;287(2):195\u2013202.","DOI":"10.1001\/jama.287.2.195"},{"key":"1741_CR20","unstructured":"ACOG Practice Bulletin No. 202. Gestational hypertension and preeclampsia. Obstet Gynecol 2019, 133(1):e1-e25."},{"issue":"4","key":"1741_CR21","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nm.2307","volume":"17","author":"TJ Wang","year":"2011","unstructured":"Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, McCabe E, Lewis GD, Fox CS, Jacques PF, Fernandez C, et al. Metabolite profiles and the risk of developing diabetes. Nat Med. 2011;17(4):448\u201353.","journal-title":"Nat Med"},{"issue":"4","key":"1741_CR22","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1172\/JCI44442","volume":"121","author":"EP Rhee","year":"2011","unstructured":"Rhee EP, Cheng S, Larson MG, Walford GA, Lewis GD, McCabe E, Yang E, Farrell L, Fox CS, O'Donnell CJ, et al. Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J Clin Invest. 2011;121(4):1402\u201311.","journal-title":"J Clin Invest"},{"key":"1741_CR23","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.","journal-title":"BMC Bioinformatics"},{"issue":"5","key":"1741_CR24","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1053\/plac.2002.0808","volume":"23","author":"D Rakheja","year":"2002","unstructured":"Rakheja D, Bennett MJ, Foster BM, Domiati-Saad R, Rogers BB. Evidence for fatty acid oxidation in human placenta, and the relationship of fatty acid oxidation enzyme activities with gestational age. Placenta. 2002;23(5):447\u201350.","journal-title":"Placenta"},{"issue":"4","key":"1741_CR25","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1161\/HYPERTENSIONAHA.110.157297","volume":"56","author":"LC Kenny","year":"2010","unstructured":"Kenny LC, Broadhurst DI, Dunn W, Brown M, North RA, McCowan L, Roberts C, Cooper GJ, Kell DB, Baker PN, et al. Robust early pregnancy prediction of later preeclampsia using metabolomic biomarkers. Hypertension. 2010;56(4):741\u20139.","journal-title":"Hypertension"},{"key":"1741_CR26","doi-asserted-by":"publisher","first-page":"857108","DOI":"10.1155\/2015\/857108","volume":"2015","author":"MP Koster","year":"2015","unstructured":"Koster MP, Vreeken RJ, Harms AC, Dane AD, Kuc S, Schielen PC, Hankemeier T, Berger R, Visser GH, Pennings JL. First-trimester serum acylcarnitine levels to predict preeclampsia: a metabolomics approach. Dis Markers. 2015;2015:857108.","journal-title":"Dis Markers"},{"issue":"5 Pt 1","key":"1741_CR27","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1097\/01.AOG.0000125699.60416.03","volume":"103","author":"IG Thiele","year":"2004","unstructured":"Thiele IG, Niezen-Koning KE, van Gennip AH, Aarnoudse JG. Increased plasma carnitine concentrations in preeclampsia. Obstet Gynecol. 2004;103(5 Pt 1):876\u201380.","journal-title":"Obstet Gynecol"},{"issue":"4","key":"1741_CR28","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nm0410-400","volume":"16","author":"DM Erion","year":"2010","unstructured":"Erion DM, Shulman GI. Diacylglycerol-mediated insulin resistance. Nat Med. 2010;16(4):400\u20132.","journal-title":"Nat Med"},{"issue":"4","key":"1741_CR29","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1093\/ajcn\/72.4.905","volume":"72","author":"JP DeLany","year":"2000","unstructured":"DeLany JP, Windhauser MM, Champagne CM, Bray GA. Differential oxidation of individual dietary fatty acids in humans. Am J Clin Nutr. 2000;72(4):905\u201311.","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"1741_CR30","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1523\/JNEUROSCI.2760-08.2009","volume":"29","author":"M Milanski","year":"2009","unstructured":"Milanski M, Degasperi G, Coope A, Morari J, Denis R, Cintra DE, Tsukumo DM, Anhe G, Amaral ME, Takahashi HK, et al. Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity. J Neurosci. 2009;29(2):359\u201370.","journal-title":"J Neurosci"},{"issue":"12","key":"1741_CR31","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.2337\/dc18-0840","volume":"41","author":"C Razquin","year":"2018","unstructured":"Razquin C, Toledo E, Clish CB, Ruiz-Canela M, Dennis C, Corella D, Papandreou C, Ros E, Estruch R, Guasch-Ferre M, et al. Plasma lipidomic profiling and risk of type 2 diabetes in the PREDIMED trial. Diabetes Care. 2018;41(12):2617\u201324.","journal-title":"Diabetes Care"},{"issue":"11","key":"1741_CR32","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1093\/aje\/kwz171","volume":"188","author":"M Ding","year":"2019","unstructured":"Ding M, Zeleznik OA, Guasch-Ferre M, Hu J, Lasky-Su J, Lee IM, Jackson RD, Shadyab AH, LaMonte MJ, Clish C, et al. Metabolome-wide association study of the relationship between habitual physical activity and plasma metabolite levels. Am J Epidemiol. 2019;188(11):1932\u201343.","journal-title":"Am J Epidemiol"},{"key":"1741_CR33","doi-asserted-by":"crossref","unstructured":"Tabung FK, Balasubramanian R, Liang L, Clinton SK, Cespedes Feliciano EM, Manson JE, Van Horn L, Wactawski-Wende J, Clish CB, Giovannucci EL, et al. Identifying metabolomic profiles of insulinemic dietary patterns. Metabolites. 2019;9(6):120.","DOI":"10.3390\/metabo9060120"},{"key":"1741_CR34","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ijcard.2017.10.026","volume":"253","author":"C Razquin","year":"2018","unstructured":"Razquin C, Liang L, Toledo E, Clish CB, Ruiz-Canela M, Zheng Y, Wang DD, Corella D, Castaner O, Ros E, et al. Plasma lipidome patterns associated with cardiovascular risk in the PREDIMED trial: a case-cohort study. Int J Cardiol. 2018;253:126\u201332.","journal-title":"Int J Cardiol"},{"issue":"4","key":"1741_CR35","doi-asserted-by":"crossref","first-page":"973","DOI":"10.3945\/ajcn.116.151159","volume":"106","author":"E Toledo","year":"2017","unstructured":"Toledo E, Wang DD, Ruiz-Canela M, Clish CB, Razquin C, Zheng Y, Guasch-Ferre M, Hruby A, Corella D, Gomez-Gracia E, et al. Plasma lipidomic profiles and cardiovascular events in a randomized intervention trial with the Mediterranean diet. Am J Clin Nutr. 2017;106(4):973\u201383.","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"1741_CR36","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1021\/acs.jproteome.6b00845","volume":"16","author":"C Virgiliou","year":"2017","unstructured":"Virgiliou C, Gika HG, Witting M, Bletsou AA, Athanasiadis A, Zafrakas M, Thomaidis NS, Raikos N, Makrydimas G, Theodoridis GA. Amniotic fluid and maternal serum metabolic signatures in the second trimester associated with preterm delivery. J Proteome Res. 2017;16(2):898\u2013910.","journal-title":"J Proteome Res"},{"issue":"8","key":"1741_CR37","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S0223-5234(02)01340-5","volume":"37","author":"S Sharma","year":"2002","unstructured":"Sharma S, Srivastava VK, Kumar A. Newer N-substituted anthranilic acid derivatives as potent anti-inflammatory agents. Eur J Med Chem. 2002;37(8):689\u201397.","journal-title":"Eur J Med Chem"},{"issue":"9","key":"1741_CR38","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/j.2042-7158.1996.tb05993.x","volume":"48","author":"JC Duffy","year":"1996","unstructured":"Duffy JC, Dearden JC, Rostron C. A QSAR study of anti-inflammatory N-arylanthranilic acids. J Pharm Pharmacol. 1996;48(9):883\u20136.","journal-title":"J Pharm Pharmacol"},{"issue":"4792","key":"1741_CR39","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1126\/science.3029864","volume":"235","author":"R Stocker","year":"1987","unstructured":"Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science. 1987;235(4792):1043\u20136.","journal-title":"Science"},{"key":"1741_CR40","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/0076-6879(90)86123-D","volume":"186","author":"R Stocker","year":"1990","unstructured":"Stocker R, McDonagh AF, Glazer AN, Ames BN. Antioxidant activities of bile pigments: biliverdin and bilirubin. Methods Enzymol. 1990;186:301\u20139.","journal-title":"Methods Enzymol"},{"issue":"4","key":"1741_CR41","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.2337\/db14-0228","volume":"64","author":"A Abbasi","year":"2015","unstructured":"Abbasi A, Deetman PE, Corpeleijn E, Gansevoort RT, Gans RO, Hillege HL, van der Harst P, Stolk RP, Navis G, Alizadeh BZ, et al. Bilirubin as a potential causal factor in type 2 diabetes risk: a Mendelian randomization study. Diabetes. 2015;64(4):1459\u201369.","journal-title":"Diabetes"},{"issue":"1","key":"1741_CR42","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1093\/ije\/dyu242","volume":"44","author":"L Wang","year":"2015","unstructured":"Wang L, Bautista LE. Serum bilirubin and the risk of hypertension. Int J Epidemiol. 2015;44(1):142\u201352.","journal-title":"Int J Epidemiol"},{"issue":"7627","key":"1741_CR43","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1136\/bmj.39366.416817.BE","volume":"335","author":"EB Magnussen","year":"2007","unstructured":"Magnussen EB, Vatten LJ, Lund-Nilsen TI, Salvesen KA, Davey Smith G, Romundstad PR. Prepregnancy cardiovascular risk factors as predictors of pre-eclampsia: population based cohort study. BMJ. 2007;335(7627):978.","journal-title":"BMJ"},{"issue":"5","key":"1741_CR44","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1097\/EDE.0b013e318225c960","volume":"22","author":"EW Harville","year":"2011","unstructured":"Harville EW, Viikari JS, Raitakari OT. Preconception cardiovascular risk factors and pregnancy outcome. Epidemiology. 2011;22(5):724\u201330.","journal-title":"Epidemiology"},{"issue":"6","key":"1741_CR45","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1161\/HYPERTENSIONAHA.116.07099","volume":"67","author":"GM Egeland","year":"2016","unstructured":"Egeland GM, Klungsoyr K, Oyen N, Tell GS, Naess O, Skjaerven R. Preconception cardiovascular risk factor differences between gestational hypertension and preeclampsia: cohort Norway study. Hypertension. 2016;67(6):1173\u201380.","journal-title":"Hypertension"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-020-01741-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-020-01741-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-020-01741-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T16:22:49Z","timestamp":1696868569000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-020-01741-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,13]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1741"],"URL":"https:\/\/doi.org\/10.1186\/s12916-020-01741-4","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,13]]},"assertion":[{"value":"7 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study has been approved by the Institutional Review Boards of Boston Medical Center and Johns Hopkins Bloomberg School of Public Health. Written informed consent was obtained from each participant.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"277"}}